Warning letter
American Analytical Chemistry Laboratories, Ltd.: warning letter of Feb 6, 2003
FDA warning letter UCM147299 · Chicago District Office
Key facts
| Reference number | UCM147299 |
|---|---|
| Company | American Analytical Chemistry Laboratories, Ltd. |
| Subject | CGMP for Finished Pharmaceuticals/Adulterated |
| Issue date | Feb 6, 2003 |
| Posted date | Feb 6, 2003 |
| Issuing office | Chicago District Office |
| Product type | Drugs |
| CFR sections cited | 211, 211.192, 211.160(a), 211.194(a)(8), 211.194(c), 210.3(b) |
| Country | 3 |
| Inspection city | Champaign |
| Inspection ZIP | 61821-2475 |
| Inspection start date | Oct 17, 2002 |
| Letter on fda.gov | web.archive.org |
At a glance
- 1–9 CFR sections cited
- OAI Linked inspection classification
- Yes Form FDA 483 issued
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About FDA warning letters
FDA warning letters notify a firm of significant regulatory violations found during an inspection or review and request prompt corrective action.
Source: U.S. Food and Drug Administration (FDA), Warning Letters · Source date: